rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Jagsonpal Pharmaceuticals Ltd. - Research Center
507789 JAGSNPHARM Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18 Mar ' 17
Income
Operating income 187.95 158.57 168.25 126.99 143.87
Expenses
Material consumed 80.80 56.23 72.93 61.29 59.32
Manufacturing expenses 0.52 0.64 1.41 1.00 2.12
Personnel expenses 53.98 50.37 46.61 41.88 40.95
Selling expenses 11.83 16.29 - - -
Adminstrative expenses 21.73 26.49 36.54 33.47 35.70
Expenses capitalised - - - - -
Cost of sales 168.87 150.04 157.49 137.64 138.10
Operating profit 19.08 8.53 10.76 -10.65 5.77
Other recurring income 4.39 2.53 - - 0.47
Adjusted PBDIT 23.47 11.06 - - 6.24
Financial expenses 1.09 0.51 0.75 0.66 2.64
Depreciation 0.51 1.13 1.02 0.32 1.99
Other write offs - - - - -
Adjusted PBT 21.87 9.41 9.00 -11.63 1.60
Tax charges 4.81 1.54 1.79 -0.08 2.53
Adjusted PAT 17.06 7.87 7.22 -11.55 -0.93
Non recurring items 0.15 - - - 12.80
Other non cash adjustments - - - - -
Reported net profit 17.21 7.87 7.22 -11.55 11.86
Earnigs before appropriation 64.90 49.00 41.92 35.02 47.09
Equity dividend 2.62 1.31 0.79 0.32 0.21
Preference dividend - - - - -
Dividend tax - - - - 0.05
Retained earnings 62.28 47.69 41.13 34.71 46.83

Mutual Fund Selector

Find the fund that is right for you
Close
Add Jagsonpal Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Jagsonpal Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close